Advertisement

Journal of Genetic Counseling

, Volume 10, Issue 1, pp 25–40 | Cite as

Factors Influencing Patients' Decisions to Decline Cancer Genetic Counseling Services

  • Katherine P. Geer
  • Mary E. Ropka
  • Wendy F. Cohn
  • Susan M. Jones
  • Susan Miesfeldt
Article

Abstract

Little is known about the factors influencing patients' decisions about whether to utilize cancer genetic counseling services. The purpose of this study is to identify potential barriers to broad utilization of such services. Of a total of 136 decliners of cancer genetic counseling services at our institution, 117 were deemed eligible to participate. Of these, 73 were randomly selected for study. A total of 37/73 (51%) agreed to participate in a semistructured telephone survey designed to assess the factors that impacted their decisions to decline cancer genetic counseling. An interview script, composed of both closed- and open-ended questions, was used to direct the survey. Interviews were audiotaped. Responses to open-ended questions were content analyzed. Of the participants, 34 were female and 36 were Caucasian. Seventy-two percent of the participants were between ages 36 and 55 years. Participants cited the following reasons for choosing not to proceed with cancer genetic counseling: concern over health insurability for self or family (n = 15); cost (n = 12); emotional impact on self or family (n = 11); no perceived benefit (n = 11); and time commitment (n = 9). These data provide an understanding of patient's attitudes and concerns impacting their decisions to decline cancer genetic counseling. This information provides guidance for the development of interventions designed to limit barriers among patients referred for such services.

attitudes cancer risk counseling genetic counseling genetic services hereditary cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. American College of Medical Genetics (1996) Statement on population screening for BRCA-1 mutation in Ashkenazi Jewish women. ACMG College Newsletter 7:9.Google Scholar
  2. American College of Obstetrics and Gynecology Committee on Genetics (1997) Breast-ovarian cancer screening. Internat J Gynecol Obstet 56:82-83.Google Scholar
  3. American Society of Clinical Oncology (1996) Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14:1730-1736.Google Scholar
  4. American Society of Human Genetics (1994) Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 55:i-iv.Google Scholar
  5. Bernhardt BA, Pyeritz RE (1989) The economics of clinical genetics services. III. Cognitive genetics services are not self-supporting. Am J Hum Genet 44:288-293.Google Scholar
  6. Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP (1999) Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17:1040-1046.Google Scholar
  7. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, Kahn MJE, McTiernan A, Offit K, Thomson E, Varricchio C (1997a) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. JAMA 277:915-919.Google Scholar
  8. Burke W, Daly M, Garger J, Botkin J, Kahn MJE, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C (1997b) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA 277:997-1003.Google Scholar
  9. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT (1995) Women' s receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85:1133-1135.Google Scholar
  10. Codori AM, Hanson R, Brandt J (1994) Self-selection in predictive testing for Huntington' s disease. Am J Med Genet 54:167-173.Google Scholar
  11. Croyle RT, Smith KR, Botkin JR, Baty B, Nash J (1997) Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 16:63-72.Google Scholar
  12. Durfy SJ, Bowen DJ, McTiernan A, Sporieder J, Burke W (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8:369-375.Google Scholar
  13. Geller G, Botkin JR, Green MJ, Press N, Biesecker BB, Wilfond B, Grana G, Daly MB, Schneider K, Kahn MJE (1997) Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 277:1467-1474.Google Scholar
  14. Giardiello FM, Brensinger JD, Petersen GM, Luce MC, Hylind LM, Bacon JA, Booker SV, Parker RD, Hamilton SR (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New Eng J Med 336:823-827.Google Scholar
  15. Hall MA, Rich SS (2000) Laws restricting health insurers' use of genetic information: Impact on genetic discrimination. Am J Hum Genet 66:293-307.Google Scholar
  16. Jones SM, Cohn WF, Miesfeldt S (1997) Physicians need more education about inherited cancer predisposition [letter]. Acad Med 72:832-833.Google Scholar
  17. Klimberg VS, Galandiuk S, Singletary ES (1999) Society of Surgical Oncology: Statement on genetic testing for cancer susceptibility. Ann Surg Oncol 6:507-509.Google Scholar
  18. Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850.Google Scholar
  19. Lerman C, Seay J, Balshem A, Audrain J (1995) Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392.Google Scholar
  20. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon SJ, Conway T, Tonin P, Lenoir G, Lynch H (1996) BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 275:1885-1892.Google Scholar
  21. Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A, Abbaszadegan MR, Harty AE, Franklin BA, Lynch JF, Lynch HT (1999) Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281:1618-1622.Google Scholar
  22. Lindor NM, Greene MH (1998) The concise handbook of family cancer syndromes. J Natl Cancer Inst 90:1039-1071.Google Scholar
  23. Loader S, Levenkron JC, Rowley P (1998) Genetic testing for breast-ovarian cancer susceptibility: A regional trial. Genet Testing 2:305-313.Google Scholar
  24. Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, Lerman C, Tonin P, Lenoir G, Serova O, Narod S (1997) A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79:2219-2228.Google Scholar
  25. McKinnon WC, Baty BJ, Bennett RL, Magee M, Neufeld-Kaiser WA, Peters KF, Sawyer JC, Schneider KA (1997) Predisposition genetic testing for late-onset disorders in adults: A position paper of the National Society of Genetic Counselors. JAMA 278:1217-1220.Google Scholar
  26. Olopade O (1996) Genetic testing of families with hereditary diseases. JAMA 276:1138-1139.Google Scholar
  27. Pasacreta JV (1999) Psychosocial issues associated with increased breast and ovarian cancer risk: Findings from focus groups. Arch Psych Nurs 13:127-136.Google Scholar
  28. Peters JA, Stopfer JE (1996) Role of the genetic counselor in familial cancer. Oncology 10:159-166.Google Scholar
  29. Petersen GM, Larkin E, Codori AM, Wang CY, Booker SV, Bacon J, Giardiello FM, Boyd PA (1999) Attitudes toward colon cancer gene testing: Survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev 8:337-344.Google Scholar
  30. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA(1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4:169-173.Google Scholar
  31. Tessaro I, Borstelmann N, Regan K, Rimer BK, Winer E (1997) Genetic testing for susceptibility to breast cancer: Findings from women' s focus groups. J Womens Health 6:317-327.Google Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2001

Authors and Affiliations

  • Katherine P. Geer
    • 1
  • Mary E. Ropka
    • 2
  • Wendy F. Cohn
    • 2
  • Susan M. Jones
    • 1
  • Susan Miesfeldt
    • 1
  1. 1.Cancer CenterUniversity of Virginia Health SystemCharlottesville
  2. 2.Department of Health Evaluation SciencesUniversity of Virginia Health SystemCharlottesville

Personalised recommendations